Evidence map›Paper›PMID 27684351›Full record

ArticleAnalytical chemistry2016

Adductomics Pipeline for Untargeted Analysis of Modifications to Cys34 of Human Serum Albumin.

Hasmik Grigoryan, William Edmands, Sixin S Lu, Yukiko Yano, Luca Regazzoni, Anthony T Iavarone, Evan R Williams, Stephen M Rappaport

Abstract read
In one paragraph

Article in Analytical chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Use of Human Serum Albumin CysAntioxidants (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  9. Article
  10. Article
  11. Pathways to Identify ElectrophilesChemical research in toxicology · 2022
    Article
  12. Article
  13. Article
  14. Quo vadis blood protein adductomics?Archives of toxicology · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Metabolism and biomarkers of heterocyclic aromatic amines in humans.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hasmik GrigoryanSchool of Public Health, University of California , Berkeley, California 94720-7356, United States.
William EdmandsSchool of Public Health, University of California , Berkeley, California 94720-7356, United States.
Sixin S LuSchool of Public Health, University of California , Berkeley, California 94720-7356, United States.
Yukiko YanoSchool of Public Health, University of California , Berkeley, California 94720-7356, United States.
Luca RegazzoniSchool of Public Health, University of California , Berkeley, California 94720-7356, United States.
Anthony T IavaroneCalifornia Institute for Quantitative Biosciences, University of California , Berkeley, California 94720, United States.
Evan R WilliamsCollege of Chemistry, University of California , Berkeley, California 94720, United States.
Stephen M RappaportSchool of Public Health, University of California , Berkeley, California 94720-7356, United States.

Funding

PROTEIN ADDUCTS AS MOLECULAR SIGNATURES OF CARCINOGEN DOSEU54ES016115 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI RAPPAPORT, STEPHEN MORRIS · 2007 to 2011
$5.3M
Microfluidic Chips for BiomonitoringR44ES022360 · NIEHS · NEWOMICS, INC · PI WANG, DAOJING · 2015 to 2016
$1.5M
Using Adductomics to Characterize Exposures to CarcinogensR33CA191159 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI RAPPAPORT, STEPHEN MORRIS · 2015 to 2017
$1.1M
NCI NIH HHS R33 CA191159NIEHS NIH HHS R44 ES022360NIEHS NIH HHS U54 ES016115
6 · The paper itself

Abstract

An important but understudied class of human exposures is comprised of reactive electrophiles that cannot be measured in vivo because they are short-lived. An avenue for assessing these meaningful exposures focuses on adducts from reactions with nucleophilic loci of blood proteins, particularly Cys34 of human serum albumin, which is the dominant scavenger of reactive electrophiles in serum. We developed an untargeted analytical scheme and bioinformatics pipeline for detecting, quantitating, and annotating Cys34 adducts in tryptic digests of human serum/plasma. The pipeline interrogates tandem mass spectra to find signatures of the Cys34-containing peptide, obtains accurate masses of putative adducts, quantitates adduct levels relative to a "housekeeping peptide", and annotates modifications based on a combination of retention time, accurate mass, elemental composition, and database searches. We used the adductomics pipeline to characterize 43 adduct features in archived plasma from healthy human subjects and found several that were highly associated with smoking status, race, and other covariates. Since smoking is a strong risk factor for cancer and cardiovascular disease, our ability to discover adducts that distinguish smokers from nonsmokers with untargeted adductomics indicates that the pipeline is suitable for use in epidemiologic studies. In fact, adduct features were both positively and negatively associated with smoking, indicating that some adducts arise from reactions between Cys34 and constituents of cigarette smoke (e.g., ethylene oxide and acrylonitrile) while others (Cys34 oxidation products and disulfides) appear to reflect alterations in the serum redox state that resulted in reduced adduct levels in smokers.

Indexed as

Cigarette SmokingCysteineHumansMass SpectrometryModels, MolecularOxidation-ReductionPeptidesSerum Albumin, HumanYoung AdultCysteinePeptidesSerum Albumin, Human

Identifiers

PMID27684351
PMCPMC5555296

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.